Psi Pharma Support Poland
KRSCompany age:
Age:
20 y. 1 m. 4 d.
Share capital:
Share capital:
50 000 PLN
Company Psi Pharma Support Poland
KRS
0000242044
NIP
5252344316
REGON
14020994100000
| Address | UL. HRUBIESZOWSKA 6B, PL-01-209, WARSZAWA | |
| Voivodeship | Masovian | |
| Phone |
|
|
| Website | psi-cro.com |
Add to phone
Scan the QR code to add the company’s contact details directly to your phone.
Management
Rogowska Agnieszka, członek zarządu
Other management members ›
Beneficiaries of
1 beneficiary
More ›
| Rating | |||
| Main industry | Other research and experimental development on natural sciences and engineering | ||
| Account number |
PL32 1030 1508 0000 0008 1906 4001
PL59 1030 1508 0000 0008 1906 4000 |
PKD codes:
72.19.Z - Other research and experimental development on natural sciences and engineering
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
70.22 - Business and other management consultancy activities
71.20.B - Inspection and issuance of opinions on the technical condition of chimneys and ventilation ducts
72.1 - Research and experimental development on natural sciences and engineering
72.2 - Research and experimental development on social sciences and humanities
73.20.Z - Market research and public opinion polling
86.90.E - Other human health activities not elsewhere classified
PSI PHARMA SUPPORT POLAND was established on 2005-09-26 and is currently located at UL. HRUBIESZOWSKA 6B, PL-01-209, WARSZAWA. The main activity of the company is scientific research and development. Other activities carried out by the company include activities of head offices and holding companies, management consulting services, market research and public opinion research, other human health activities, scientific research in social sciences, technical testing and analysis. As per the latest entry in the National Court Register, the current management board of the company comprises 3 individual(s). The most recent update in the National Court Register was recorded on 2025-06-30.